NCT02193464

Brief Summary

The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Sep 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Sep 2014Dec 2026

First Submitted

Initial submission to the registry

July 16, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 17, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
11.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

11.3 years

First QC Date

July 16, 2014

Last Update Submit

January 8, 2021

Conditions

Idiopathic Chronic Inflammatory Bowel Disease

Keywords

inflammatory bowel disease, registry, incidence, Korea

Outcome Measures

Primary Outcomes (1)

  • All newly diagnosed cases

    In one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.

    one year

Secondary Outcomes (1)

  • All operation cases

    one year

Other Outcomes (1)

  • All cases of disease relapse

    one year

Study Arms (1)

inflammatory bowel disease

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with inflammatory bowel disease from primary, secondary, and tertiary hospital in Daegu-Gyeongbuk province of Korea.

You may qualify if:

  • Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
  • Followed up for at least 6 months for the correct diagnosis

You may not qualify if:

  • Patients who do not live in Daegu-Gyeongbuk province

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keimyung University Dongsan Medical Center

Daegu, 700-712, South Korea

RECRUITING

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Eun Soo Kim, MD, PhD

    Keimyung University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eun Soo Kim, MD. PhD

CONTACT

+82-53-250-7088dandy813@hanmail.net

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 16, 2014

First Posted

July 17, 2014

Study Start

September 1, 2014

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

January 12, 2021

Record last verified: 2021-01

Locations

KR(1)